Liontrust Investment Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Sell
31,014
-74,256
-71% -$19.7M 0.22% 74
2026
Q1
$11.5M Buy
105,270
+52,284
+99% +$7.45M 0.2% 83
2025
Q4
$8.81M Buy
52,986
+23,757
+81% +$3.97M 0.13% 113
2025
Q3
$5.72M Sell
29,229
-23,120
-44% -$3.8M 0.08% 128
2025
Q2
$4.73M Buy
52,349
+20,220
+63% +$1.6M 0.07% 125
2025
Q1
$1.92M Buy
32,129
+16,092
+100% +$1.49M 0.03% 150
2024
Q4
$2.12M Buy
+16,037
New +$1.51M 0.03% 146

Other funds holding ALAB

Liontrust Investment Partners's ALAB Position: Q2 2026 in Review

Liontrust Investment Partners reduced its Astera Labs (ALAB) stake by 71% in Q2 2026, selling an estimated $19.7M and leaving 31,014 shares worth $15M. The position accounts for 0.22% of the portfolio, ranked #74.

Liontrust Investment Partners first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Liontrust Investment Partners held 31,014 shares of Astera Labs worth $15M as of Q2 2026.
  • Liontrust Investment Partners sold 74,256 Astera Labs shares in Q2 2026, an estimated $19.7M.
  • Astera Labs made up 0.22% of Liontrust Investment Partners's portfolio in Q2 2026, its #74 holding.
  • Liontrust Investment Partners first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.